New system of “strain engineering” can change a material’s optical, electrical, and thermal properties.
Analysis of blood from patients with sickle-cell disease reveals how cell clumping begins.
Diamond nanoneedles have strength approaching the theoretical maximum.
The brittle material can turn flexible when made into ultrafine needles, researchers find.
Materials with a special kind of boundary between crystal grains can deform in unexpected ways.
Microfluidic device uses acoustics to quickly analyze blood for signatures of cancer and other diseases. (Also see Video)
The study established a framework for understanding the mechanics that underlies vesicle formation, which can be used to help develop liquid biopsies for a range of diseases and to develop new drug delivery vehicles.
An interdisciplinary, international group of researchers has found new biophysical markers that could help improve the understanding of treatments for sickle cell disease.
Researchers used computer modeling to show how the spleen maintains the quality of red blood cells in the bloodstream. The findings may provide insights into conditions that lead to anemia.
Computer model finds slits in the spleen impose a “physical fitness test” on red blood cells.
Technique could enable 3-D printing of cellular structures for tissue engineering.
Low-amplitude repeated stretching can eliminate crystal defects in nanoscale metal parts.
Acoustic device can rapidly isolate circulating tumor cells from patient blood samples.
Microfluidic device allows for predicting the behavior of patients’ sickle cells.
Acoustic device that separates tumor cells from blood cells could help assess cancer’s spread.
A new humanized mouse model for malaria infection was developed. The study reveals immune cells that are critical to combating the parasite in early stages of infection.
A group of 62 elite Chinese and foreign scientists were formally inducted as members of the Chinese Academy of Sciences.
New prototype device recognizes electrical properties of infected cells as signatures of disease.
National Science Foundation Director Subra Suresh announced that he will step down from his current role at NSF at the end of March to accept an appointment as Carnegie Mellon University’s ninth president, effective July 1.